Idiosyncratic Drug-Induced Liver Injury Due to Ciprofloxacin: A Report of Two Cases and Review of the Literature
暂无分享,去创建一个
Mladen Jecmenica | M. Radulovic | Milan Radovanovic | Tetyana Dushenkovska | Ivan Cvorovic | Natasa Radovanovic | Vimala Ramasamy | Katarina Milosavljevic | Jelena Surla | Miroslav Radulovic | Tamara Milovanovic | Igor Dumic | Tamara Milovanovic | Igor Dumic | M. Jecmenica | Milan Radovanovic | V. Ramasamy | Jelena Surla | Nataša Radovanović | K. Milosavljevic | Tetyana Dushenkovska | Ivan Čvorović | Nataša Radovanovič | Tamara Milovanović
[1] P. Ganey,et al. Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.
[2] James H. Lewis,et al. The rational use of potentially hepatotoxic medications in patients with underlying liver disease , 2002, Expert opinion on drug safety.
[3] J. Beizer,et al. Possible Ciprofloxacin-Induced Acute Cholestatic Jaundice , 1994, The Annals of pharmacotherapy.
[4] M. Brezis,et al. Fatal hepatic failure associated with ciprofloxacin , 1994, The Lancet.
[5] Layth Al-Jashaami,et al. Ciprofloxacin Exposure Leading to Fatal Hepatotoxicity: An Unusual Correlation , 2016, The American journal of case reports.
[6] Michael Merz,et al. Drug-induced liver injury: recent advances in diagnosis and risk assessment , 2017, Gut.
[7] William M. Lee. Drug-induced acute liver failure. , 2013, Clinics in liver disease.
[8] William M. Lee,et al. Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset. , 2014, Gastroenterology.
[9] E. Cholongitas,et al. Ciprofloxacin-induced acute cholestatic hepatitis. , 2009, Annals of hepatology.
[10] G. Klőppel,et al. Cholestatic hepatitis related to quinolones: a report of two cases. , 1995, Journal of hepatology.
[11] Z. Goodman,et al. Ciprofloxacin-induced acute cholestatic liver injury and associated renal failure. Case report and review. , 2008, Minerva gastroenterologica e dietologica.
[12] M. Raza,et al. Ciprofloxacin-induced Hepatotoxicity in a Healthy Young Adult , 2017, Cureus.
[13] M. Goetz,et al. Non-Fatal Acute Liver Injury Possibly Related to High-Dose Ciprofloxacin , 2003, European Journal of Clinical Microbiology and Infectious Diseases.
[14] T. Alempijevic,et al. Drug-induced liver injury: Do we know everything? , 2017, World journal of hepatology.
[15] Neil Kaplowitz,et al. Idiosyncratic drug hepatotoxicity , 2005, Nature Reviews Drug Discovery.
[16] R. Fontana,et al. An update on drug induced liver injury. , 2011, Minerva gastroenterologica e dietologica.
[17] S. Zaidi. Hepatitis associated with amoxicillin/clavulanic acid and/or ciprofloxacin. , 2003, The American journal of the medical sciences.
[18] Muhammad M Mamdani,et al. Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study , 2012, Canadian Medical Association Journal.
[19] A. Geubel,et al. Delayed and prolonged cholestatic hepatitis with ductopenia after long-term ciprofloxacin therapy for Crohn's disease. , 2002, Journal of hepatology.
[20] V. Lehr,et al. Fulminant Hepatic Failure Possibly Related to Ciprofloxacin , 1992, The Annals of pharmacotherapy.
[21] M. Alcalde,et al. Liver disfunction due to ciprofloxacin. , 1995, Acta gastro-enterologica Belgica.
[22] M. Vergara,et al. Recurrent drug-induced liver injury (DILI) with ciprofloxacin and amoxicillin/clavulanic. , 2015, Revista Espanola de Enfermedades Digestivas.
[23] R. Fontana,et al. The diagnosis and management of idiosyncratic drug‐induced liver injury , 2018, Liver international : official journal of the International Association for the Study of the Liver.
[24] H. Kurt,et al. Unexpected severe hepatotoxicity of ciprofloxacine: two case reports , 2011, Drug and chemical toxicology.
[25] L. Terracciano,et al. Ciprofloxacin-induced acute liver injury: case report and review of literature , 2003, Virchows Archiv.
[26] R. Andrade,et al. Hepatic safety of antibiotics used in primary care , 2011, The Journal of antimicrobial chemotherapy.
[27] R. Fontana,et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. , 2008, Gastroenterology.
[28] S. Olafsson,et al. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. , 2013, Gastroenterology.
[29] N. Høiby,et al. The efficacy and safety of ciprofloxacin and ofloxacin in chronic Pseudomonas aeruginosa infection in cystic fibrosis. , 1987, The Journal of antimicrobial chemotherapy.
[30] L. Zechiedrich,et al. Wicked: The untold story of ciprofloxacin , 2018, PLoS pathogens.
[31] K. Bhagirath. A case report of highly suspected ciprofloxacin-induced hepatotoxicity. , 2008, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.
[32] G. Joshi,et al. Ciprofloxacin-induced cholestatic jaundice. , 2007, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.
[33] N. Kaplowitz,et al. Mechanisms of drug-induced liver injury. , 2013, Clinics in liver disease.
[34] William M. Lee,et al. ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury , 2014, The American Journal of Gastroenterology.
[35] J. Andreu,et al. Severe Ciprofloxacin-Induced Acute Hepatitis , 2001, European Journal of Clinical Microbiology and Infectious Diseases.
[36] H. Conjeevaram,et al. Clinical and histopathologic features of fluoroquinolone-induced liver injury. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[37] M. Maes,et al. Drug-induced liver injury: mechanisms, types and biomarkers. , 2013, Current medicinal chemistry.
[38] D. Harnois. Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States , 2009 .
[39] Y. Sammour,et al. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Secondary to Furosemide: Case Report and Review of Literature , 2018, The American journal of case reports.
[40] G. Danan,et al. Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. , 1993, Journal of clinical epidemiology.
[41] D. Adams,et al. Mechanisms of immune-mediated liver injury. , 2010, Toxicological Sciences.
[42] H. Baba,et al. Idiosyncratic drug‐induced liver injury: A short review , 2017, Hepatology communications.
[43] R. Andrade,et al. Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists. , 2007, World Journal of Gastroenterology.
[44] J. Uetrecht,et al. Immunoallergic Drug-Induced Liver Injury in Humans , 2009, Seminars in liver disease.
[45] J. Gurka,et al. Probable ciprofloxacin induced cholestasis. , 1995, Australian and New Zealand journal of medicine.
[46] C. Bénichou. Criteria of drug-induced liver disorders. Report of an international consensus meeting. , 1990, Journal of hepatology.
[47] N. Chalasani,et al. Risk factors for idiosyncratic drug-induced liver injury. , 2010, Gastroenterology.
[48] William M. Lee,et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. , 2009, Gastroenterology.
[49] Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an international consensus meeting. , 1990, International journal of clinical pharmacology, therapy, and toxicology.
[50] Luis Rodrigo,et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. , 2005, Gastroenterology.
[51] P. Tulkens,et al. Terms and Conditions for Use of Pdf , 2022 .
[52] W. Silverman,et al. Cholestatic jaundice induced by ciprofloxacin. , 1997, Digestive diseases and sciences.
[53] J. Villeneuve,et al. Suspected Ciprofloxacin-Induced Hepatotoxicity , 1995, The Annals of pharmacotherapy.